Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: A randomized multicenter study

Journal of the American College of Cardiology

Volumn 44, Issue 8, 2004, Pages 1557-1566

  Pérez Gómez, Francisco ^a   Alegría, Eduardo ^b   Berjón, Jesus ^c   Iriarte, Jose A ^d   Zumalde, Javier ^e   Salvador, Antonio ^f   Mataix, Luis ^g  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c Universidad Pública de Navarra   (Spain)

^d HOSPITAL DE BASURTO   (Spain)

^e HOSPITAL DE GALDAKAO   (Spain)

^f HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^g NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; TRIFLUSAL;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG EFFICACY; DRUG SAFETY; EMBOLISM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE STENOSIS; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STOMACH HEMORRHAGE; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; ULCER; VALVULAR HEART DISEASE;

ACENOCOUMAROL; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CAUSE OF DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EMBOLISM; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; SALICYLATES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 5644295138     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.05.084     Document Type: Article

References (27)

1. P.A. Wolf, R.D. Abbot, W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
2. V. Fuster, L.E. Ryden, R.W Asinger ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and Policy Conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology Eur Heart J 22 2001 1852 1923
3. P. Petersen, G. Boysen, J Godtfredsen Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study Lancet 1 1989 175 179
4. R.G. Hart, O. Benavente, R McBride Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 1999 492 501
5. J.A. Cairns, S.J. Connolly Nonrheumatic atrial fibrillation Risk of stroke and role of antithrombotic therapy Circulation 84 1991 469 481
6. Atrial Fibrillation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomised controlled trials Arch Intern Med 154 1994 1449 1457
7. Stroke Prevention in Atrial Fibrillation III Investigators Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial Lancet 348 1996 633 638
8. A.L. Gullov, B.G. Koefoed, P Petersen Fixed minidose warfarin and aspirin alone and in combination vs. adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study Arch Intern Med 158 1998 1513 1521
9. N. Edvardson, S. Juul-Möller, R Omblus Effects of low dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation J Intern Med 254 2003 95 9101
10. M. Hurlen, M. Abdelnoor, P Smith Warfarin, aspirin, or both after myocardial infarction N Engl J Med 347 2002 969 974
11. W. McNeely, K.L. Goa Triflusal Drugs 55 1998 823 833
12. J.M. Cruz-Fernandez, L. Lopez-Bescos, D Garcia-Dorado Randomised comparative trial of triflusal and aspirin following acute myocardial infarction Eur Heart J 21 2000 457 465
13. J. Matías-Guiu, J.M. Ferro, J Alvarez-Sabín Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction The TACIP study: a randomised, double blind, multicenter trial Stroke 34 2003 840 848
14. C.S. Landefeld, P.A. Anderson, L.T Goodnough The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy J Clin Epidemiol 42 1989 711 718
15. Stroke Prevention in Atrial Fibrillation Investigators Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation Stroke Prevention in Atrial Fibrillation II Study Lancet 343 1994 687 691
16. EAFT (European Atrial Fibrillation Trial) Study Group Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke Lancet 342 1993 1255 1262
17. A.G.G. Turpie, M. Gent, A Laupacis A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement N Engl J Med 329 1993 524 529
18. E.M. Hylek, S.J. Skates, M.A Sheehan An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation N Engl J Med 335 1996 540 546
19. The SPAF IIII Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators Patients with non-valvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study JAMA 279 1998 1273 1277
20. Italian Federation of Anticoagulation Clinics A guide to oral anticoagulation treatment: recommendations of the Italian Federation of Anticoagulation Clinics (FCSA) Haematologica/J Hematol 88 Suppl 2 2003 1 52
21. C. van Walraven, R.G. Hart, D.E Singer Oral anticoagulants vs. aspirin in nonvalvular atrial fibrillation JAMA 288 2002 2441 2448
22. R. Altman, F. Boullon, J Rouvier Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves J Thorac Cardiovasc Surg 72 1976 127 129
23. M. Hurlen, J. Erikssen, P Smith Comparison of bleeding complications of warfarin and warfarin plus acetylsalicylic acid: a study in 3166 outpatients J Intern Med 236 1994 299 304
24. J.H. Chesebro, V. Fuster, L.R Elveback Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared to dipyridamole Am J Cardiol 51 1983 1537 1541
25. F.W. Verheugt Bleeding risk of combined oral anticoagulation and antiplatelet therapy in cardiovascular disease J Cardiovasc Risk 3 1996 229 232
26. P.D. Stein, J.S. Alpert, J.E Dalen Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves Chest 114 1998 602-10S
27. Executive Steering Committee on behalf of the SPORTIF III Investigators Stroke prevention with oral direct thrombin inhibitor ximegalatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial Lancet 362 2003 1691 1698